CogniCell Advanced
Natural health product licensed in Canada
- Licence holder
- Max Gain Labs Ltd.
- NPN or DIN-HM
- 80085021
- Status
- Active licence
- Licence date
- 8 May 2018
- Revision date
- 10 August 2018
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Conditions légales
Ginkgo biloba L.: L'étiquetage des compléments alimentaires qui contiennent la feuille de la plante Ginkgo biloba L. doit comporter un avertissement avec la teneur suivante: "Consultez votre médecin en cas de prise simultanée d'anticoagulants."
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Folate Source : Folate | 133.33 mcg | Not calculated |
| Eleutherococcus senticosus Source : Racine Extract : Matériel brut sec Extraction ratio : 10:1 Dry plant equivalent : 750 mg | 75 mg | Not calculated |
| Acide gamma-aminobutyrique Source : Acide 4-aminobutanoïque | 33.3 mg | Not calculated |
| Ginkgo biloba Source : Feuille Extract : Matériel brut sec Extraction ratio : 50:1 Dry plant equivalent : 2,500 mg Potency : 24 % Flavonoid glycosides | 50 mg | Not calculated |
| Bacopa monnieri Source : Sommité Extract : Matériel brut sec Extraction ratio : 12:1 Dry plant equivalent : 1,800 mg Potency : 50 % Bacosides A and B | 150 mg | Not calculated |
Non-medicinal ingredients
Silicate de calcium, Cellulose microcristalline, Dioxyde de silicium, Gélatine
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19 years | 2 Capsule | 1 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Bacopa monnieri helps to support cognitive health and/or brain function. Eleuthero is used in Herbal Medicine to help improve mental and/or physical performance after periods of mental and/or physical exertion. Ginkgo helps to enhance memory in adults. GABA helps to temporarily promote relaxation. Ginkgo helps to enhance cognitive function in adults. Eleuthero is used in Herbal Medicine as a tonic to help relieve general debility and/or to aid during convalescence. Dl-alpha-lipoic acid provides antioxidants for the maintenance of good health.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Consult a health care practitioner prior to use if you are pregnant, breastfeeding, or have diabetes or any type of acute infection. Consult a health care practitioner if symptoms persist or worsen. Consult a health care practitioner prior to use if you are taking medications for diabetes, high blood pressure, or seizures. If you experience symptoms of hypoglycaemia including feeling of anxiety, dizziness, tremor, sweating, nausea or headache, discontinue use and consult a health care practitioner.
- Contre-indications
Do not use if you have high blood pressure. Do not use if you are taking health products that affect blood coagulation (e.g. blood thinners, clotting factor replacements, acetylsalicylic acid, ibuprofen, fish oils, vitamin E) as this may increase the risk of spontaneous bleeding.
Source
Official Health Canada record, licence 80085021
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2018. Photograph the packaging to check whether it has changed. Photograph the packaging